[go: up one dir, main page]

MX2007005518A - Uso de acetil l-carnitina en combinacion con propionil l-carnitina y sildenafil para el tratamiento de disfuncion erectil. - Google Patents

Uso de acetil l-carnitina en combinacion con propionil l-carnitina y sildenafil para el tratamiento de disfuncion erectil.

Info

Publication number
MX2007005518A
MX2007005518A MX2007005518A MX2007005518A MX2007005518A MX 2007005518 A MX2007005518 A MX 2007005518A MX 2007005518 A MX2007005518 A MX 2007005518A MX 2007005518 A MX2007005518 A MX 2007005518A MX 2007005518 A MX2007005518 A MX 2007005518A
Authority
MX
Mexico
Prior art keywords
carnitine
sildenafil
propionyl
acetyl
treatment
Prior art date
Application number
MX2007005518A
Other languages
English (en)
Inventor
Aleardo Koverech
Giorgio Cavallini
Original Assignee
Sigma Tau Ind Farmaceuti
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Ind Farmaceuti filed Critical Sigma Tau Ind Farmaceuti
Publication of MX2007005518A publication Critical patent/MX2007005518A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A61K31/4155—1,2-Diazoles non condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/191—Carboxylic acids, e.g. valproic acid having two or more hydroxy groups, e.g. gluconic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4418—Non condensed pyridines; Hydrogenated derivatives thereof having a carbocyclic group directly attached to the heterocyclic ring, e.g. cyproheptadine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

El uso de acetil L-carnitina en combinacion con propionil L-carnitina y sildenafil es descrito para la preparacion de un medicamento y/o producto dietetico para el tratamiento de disfuncion erectil secundaria para todas aquellas condiciones en las cuales hay afliccion o dano iatrogenico de la pelvis menor dentro de la cual corren los haces neurovasculares del pene.
MX2007005518A 2004-11-11 2005-10-19 Uso de acetil l-carnitina en combinacion con propionil l-carnitina y sildenafil para el tratamiento de disfuncion erectil. MX2007005518A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT000561A ITRM20040561A1 (it) 2004-11-11 2004-11-11 Uso della acetil l-carnitina in combinazione con propionil l-carnitina e sildenafil per il trattamento della disfunzione erettile.
PCT/EP2005/011238 WO2006050794A1 (en) 2004-11-11 2005-10-19 Use of acetyl l-carnitine in combination with propionyl l-carnitine and sildenafil for the treatment of erectile dysfunction

Publications (1)

Publication Number Publication Date
MX2007005518A true MX2007005518A (es) 2007-05-18

Family

ID=35501123

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2007005518A MX2007005518A (es) 2004-11-11 2005-10-19 Uso de acetil l-carnitina en combinacion con propionil l-carnitina y sildenafil para el tratamiento de disfuncion erectil.

Country Status (16)

Country Link
US (1) US8003652B2 (es)
EP (1) EP1811988B1 (es)
JP (1) JP5080263B2 (es)
KR (1) KR101455275B1 (es)
AT (1) ATE456950T1 (es)
CA (1) CA2585654C (es)
CY (1) CY1110239T1 (es)
DE (1) DE602005019251D1 (es)
DK (1) DK1811988T3 (es)
ES (1) ES2339265T3 (es)
IT (1) ITRM20040561A1 (es)
MX (1) MX2007005518A (es)
PL (1) PL1811988T3 (es)
PT (1) PT1811988E (es)
SI (1) SI1811988T1 (es)
WO (1) WO2006050794A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010222347A (ja) * 2009-02-24 2010-10-07 Daiichi Sankyo Healthcare Co Ltd Ｐｄｅ５阻害剤及びカルニチンを含有する医薬組成物
WO2012000634A1 (de) 2010-06-29 2012-01-05 Georg Bambach Pharmazeutische zusammensetzung zur behandlung von erektiler dysfunktion
WO2018070971A1 (ru) * 2016-10-10 2018-04-19 Товарыство З Обмэжэною Видповидальнистю Науково-Выробныча Фирма "Микрохим" Фармацевтическая композиция в форме оромукозного спрея для лечения эректильной дисфункции и легочной артериальной гипертензии

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1077260B1 (en) 1999-08-13 2010-03-31 Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts Parvovirus NS1 variants
IT1306722B1 (it) * 1999-10-08 2001-10-02 Sigma Tau Healthscience Spa Composizione per la prevenzione e/o il trattamento di disfunzionicircolatorie, comprendente derivati della l-carnitina ed estratti di
JP2001233770A (ja) * 2000-02-23 2001-08-28 Dountsuendorufaa Udo 勃起機能不全治療用の経口薬の組合わせ
ITRM20010621A1 (it) * 2001-10-18 2003-04-18 Aldo Fassi Sali metallici non igroscopici e idrosolubili di alcanoil l-carnitine, integratori dietetici che li contengono e kit dietetici, per contrast
ITRM20010708A1 (it) * 2001-12-04 2003-06-04 Sigma Tau Ind Farmaceuti Uso di una alcanoil l-carnitina per il trattamento della disfunzione erettile.
ITRM20020620A1 (it) * 2002-12-13 2004-06-14 Sigma Tau Ind Farmaceuti Uso delle carnitine per la prevenzione e/o il trattamento dei disturbi causati dall'andropausa.

Also Published As

Publication number Publication date
US8003652B2 (en) 2011-08-23
ITRM20040561A1 (it) 2005-02-11
DE602005019251D1 (de) 2010-03-25
CA2585654C (en) 2013-04-02
WO2006050794A1 (en) 2006-05-18
JP2008531466A (ja) 2008-08-14
CA2585654A1 (en) 2006-05-18
ATE456950T1 (de) 2010-02-15
PL1811988T3 (pl) 2010-07-30
PT1811988E (pt) 2010-04-08
EP1811988A1 (en) 2007-08-01
SI1811988T1 (sl) 2010-10-29
DK1811988T3 (da) 2010-05-17
EP1811988B1 (en) 2010-02-03
CY1110239T1 (el) 2015-01-14
ES2339265T3 (es) 2010-05-18
JP5080263B2 (ja) 2012-11-21
US20080090906A1 (en) 2008-04-17
KR101455275B1 (ko) 2014-10-27
KR20070085961A (ko) 2007-08-27

Similar Documents

Publication Publication Date Title
AR059817A1 (es) "uso de sacaridos no digeribles para proporcionarle a un nino el mejor comienzo luego del nacimiento"
ZA200608024B (en) Use of flibanserin in the treatment of premenstrual and other female sexual disorders
MX2009004696A (es) Uso de 3-alfa-androestandiol, opcionalmente en combinacion con un inhibidor pde5, en el tratamiento de disfuncion sexual.
IL191280A0 (en) Pharmaceutical combinations comprising testosterone in the treatment of female sexual dysfunction
AU304216S (en) Basketball bottle
AU302138S (en) Cover flap for confectionary product container
MXPA06013133A (es) Formulaciones farmaceuticas y usos de las mismas en el tratamiento de la disfuncion sexual femenina.
PL1811988T3 (pl) Zastosowanie acetylo-L-karnityny w połączeniu z propionylo-L-karnityną i sildenafilem do leczenia zaburzenia erekcji
WO2009099543A3 (en) Device for perineal massage and method of use
CY1109051T1 (el) Χρηση καρνιτινων για την προληψη και/ή θεραπεια διαταραχων που προκαλουνται απο την ανδροπαυση
NZ599570A (en) Pelvic splint
SI1492521T1 (sl) Kombinirana uporaba l-karnitina, acetil l-karnitina in propil l-karnitina za zdravljenje oligoastenoteratospermije
TW200605891A (en) Use of 7-t-butoxyiminomethylcamptothecin for the preparation of a medicament for the treatment of uterine neoplasms
PH12014500597A1 (en) Pelvic immobilizer
Serels et al. Erratum to: Preliminary findings with the Solyx™ single-incision sling system in female stress urinary incontinence
AU302963S (en) A labour of love - heat hug belt
AU313291S (en) Milking device
GR1004962B (el) Θεραπευτικο προιον με βαση την ριζα του κυκλαμινου και μεθοδος παρασκευης του.

Legal Events

Date Code Title Description
FG Grant or registration